Characteristics and Predictive Value of PD-L1 Status in Real-World Non–Small Cell Lung Cancer Patients

Journal of Immunotherapy ◽

10.1097/cji.0000000000000226 ◽

2018 ◽

Vol 41 (6) ◽

pp. 292-299 ◽

Author(s):

Jeng-Sen Tseng ◽

Tsung-Ying Yang ◽

Chih-Ying Wu ◽

Wen-Hui Ku ◽

Kun-Chieh Chen ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Predictive Value ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Pyrotinib in HER2 Heterogeneously Mutated or Amplified Advanced Non-small Cell Lung Cancer Patients: A Retrospective Real-world Study (PEARL)

Journal of the National Cancer Center ◽

10.1016/j.jncc.2021.08.001 ◽

2021 ◽

Author(s):

Guangjian Yang ◽

Xuezhi Hao ◽

Jiaqi Hu ◽

Keke Dong ◽

Haiyan Xu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Discovery and Validation of Predictive Biomarkers of Survival for Non-small Cell Lung Cancer Patients Undergoing Radical Radiotherapy: Two Proteins With Predictive Value

EBioMedicine ◽

10.1016/j.ebiom.2015.06.013 ◽

2015 ◽

Vol 2 (8) ◽

pp. 841-850 ◽

Author(s):

Michael J. Walker ◽

Cong Zhou ◽

Alison Backen ◽

Maria Pernemalm ◽

Andrew J.K. Williamson ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Predictive Value ◽

Predictive Biomarkers ◽

Radical Radiotherapy ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Abstract 1616: Characterizing differences in checkpoint inhibitor biomarkers in a real-world cohort of stage III and IV non-small cell lung cancer patients

10.1158/1538-7445.am2021-1616 ◽

2021 ◽

Author(s):

Yinjie Gao ◽

Michelle M. Stein ◽

Prerna Jain ◽

Denise Lau ◽

Kimberly L. Blackwell ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Checkpoint Inhibitor ◽

Stage Iii ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapy

Translational Lung Cancer Research ◽

10.21037/tlcr-21-681 ◽

2021 ◽

Vol 10 (9) ◽

pp. 3782-3792

Author(s):

Xin Yu ◽

Jiaqi Li ◽

Lingyun Ye ◽

Jing Zhao ◽

Mengqing Xie ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Mutant ◽

Download Full-text

FP10.01 The Efficacy of Immunotherapy in non-Small Cell Lung Cancer Patients with Uncommon Mutations: a Real World Research from Single Site

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.08.239 ◽

2021 ◽

Vol 16 (10) ◽

pp. S962

Author(s):

Y. Cheng ◽

Y. Zhang ◽

Y. Liu ◽

X. Liu ◽

C. Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Single Site ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

EP1.01-05 EGFR-2013-CPHG, a Real-World Study of EGFR Mutant Advanced Non-Small-Cell Lung Cancer Patients Treated with Erlotinib

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.1988 ◽

2019 ◽

Vol 14 (10) ◽

pp. S916

Author(s):

D. Debieuvre ◽

J. Tredaniel ◽

L. Moreau ◽

S. Larivé ◽

J. Le Treut ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Download Full-text

P2.01-12 Ramucirumab+Docetaxel Usage Following Rapid Disease Progression in Real World Advanced Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.1066 ◽

2018 ◽

Vol 13 (10) ◽

pp. S669

Author(s):

M. Batus ◽

C. Molife ◽

J. Clarke ◽

V. Stefaniak ◽

K. Winfree ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Disease Progression ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Rapid Disease Progression ◽

Lung Cancer Patients

Download Full-text

Real-World Outcomes for Advanced Non-Small Cell Lung Cancer Patients Treated With a PD-L1 Inhibitor Beyond Progression

Clinical Lung Cancer ◽

10.1016/j.cllc.2020.04.008 ◽

2020 ◽

Vol 21 (5) ◽

pp. 389-394.e3

Author(s):

Thomas E. Stinchcombe ◽

Rebecca A. Miksad ◽

Anala Gossai ◽

Sandra D. Griffith ◽

Aracelis Z. Torres

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

The Potential Predictive Value of Cyclooxygenase-2 Expression and Increased Risk of Gastrointestinal Hemorrhage in Advanced Non–Small Cell Lung Cancer Patients Treated with Erlotinib and Celecoxib

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-07-4013 ◽

2008 ◽

Vol 14 (7) ◽

pp. 2088-2094 ◽

Author(s):

Mary J. Fidler ◽

Athanassios Argiris ◽

Jyoti D. Patel ◽

David H. Johnson ◽

Alan Sandler ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Gastrointestinal Hemorrhage ◽

Predictive Value ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Download Full-text

P2.16-22 Predictive Analytic of Survival Using a Neural Network in a Real World Cohort of Advanced Non Small Cell Lung Cancer Patients

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.1889 ◽

2019 ◽

Vol 14 (10) ◽

pp. S874

Author(s):

L. Pino ◽

A. Ospina ◽

I. Triana ◽

J. Pino ◽

C. Camelo ◽

...

Keyword(s):

Neural Network ◽

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text